List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #47,901 to #47,950.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. SUR2ASulfonylurea receptor
  2. SUR2BSulfonylurea receptor
  3. SURVIVESurvival Of Patients With Acute Heart Failure In Need Of Intravenous Inotropic Support
  4. SUTAMIDouble-Blind Multicenter Comparison Of The Efficacy And Safety Of Saruplase And Urokinase In The Treatment Of Acute Myocardial Infarction: Report Of The Sutami Study Group
  5. SVCSuperior vena cava syndrome
  6. SVCOSuperior vena cava syndrome
  7. SVCSSuperior vena cava syndrome
  8. SVC SyndromeSuperior vena cava syndrome
  9. SVC obstructionSuperior vena cava syndrome
  10. SVC syndromeSuperior vena cava syndrome
  11. SVGSaphenous vein graft
  12. SVG AnatomySaphenous vein graft anatomy
  13. SVGsSaphenous vein graft
  14. SVRVascular resistance
  15. SVTSupraventricular tachycardia
  16. SVT resident survival guideNarrow complex tachycardia resident survival guide
  17. SVT vs VTWide complex tachycardia differential diagnosis
  18. SVT with aberrancyWide complex tachycardias
  19. SVT with aberrant conductionWide complex tachycardias
  20. SVTsSupraventricular tachycardia
  21. SVZSubventricular zone
  22. SWEDESSwedish Early Decision Trial
  23. SWIFTShould We Intervene Following Thrombolysis?
  24. SWISHSwedish Isradipine Study In Hypertension
  25. SWISSI IISwiss Interventional Study On Silent Ischemia Type II
  26. SWITCHSwitching From Lovenox To Angiomax In Patients With Acute Coronary Syndromes Without St Elevation Undergoing Pci
  27. SWORDSurvival With Oral D-Sotalol Trial
  28. SYMBIOT IIIA Prospective, Randomized Trial Of A Self-Expanding Ptfe Stent Graft During Svg Intervention - Late Results
  29. SYMPHONY ISibrafiban Versus Aspirin To Yield Maximum Protection From Ischemic Heart Events Post-Acute Coronary Syndromes
  30. SYMPHONY IIRandomized Trial Of Aspirin, Sibrafiban, Or Both For Secondary Prevention After Acute Coronary Syndromes
  31. SYNCOPESyncope
  32. SYNERGYSuperior Yield Of The New Strategy Of Enoxaparin, Revascularization, And Glycoprotein IIb/IIia Inhibitors
  33. SYNERGY-PCIA Prospective, Randomized Trial Of Enoxaparin And Unfractionated Heparin In Patients With Acute Coronary Syndromes - Results In Patients Undergoing Percutaneous Coronary Intervention
  34. SYNTAXSynergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery
  35. SYNTAX ScoreSynergy Between Percutaneous Coronary Intervention With Taxus And Cardiac Surgery#SYNTAX score
  36. SYNTAX scoreSynergy Between Percutaneous Coronary Intervention With Taxus And Cardiac Surgery
  37. SZASchizoaffective disorder
  38. S aureusStaphylococcus aureus
  39. S programming languageS (programming language)
  40. S waveQRS complex#S wave
  41. Sa blockSinoatrial block
  42. Sa nodal blockSinoatrial block
  43. SaagSerum-ascites albumin gradient
  44. SabiaBrazilian hemorrhagic fever
  45. Sabia virusBrazilian hemorrhagic fever
  46. Sabinas syndromeSabinas brittle hair syndrome
  47. SabrilVigabatrin
  48. SaccadesSaccade
  49. Saccadic movementSaccade
  50. SaccharidaseSaliva

View ( | ) (20 | 50 | 100 | 250 | 500)